Cargando…

Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels

BACKGROUND: Accumulating evidence suggests that serum vascular endothelial growth factor (VEGF) in many neurobiological processes potentially contributes to the pathophysiology of psychiatric disorders, particularly cognitive decline. The purpose of this study was to explore the differences in neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yaqin, Xiao, Wenhuan, Chen, Kuanyu, Zhan, Qiongqiong, Ye, Fei, Tang, Xiaowei, Zhang, Xiaobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915945/ https://www.ncbi.nlm.nih.gov/pubmed/31842818 http://dx.doi.org/10.1186/s12888-019-2397-8

Ejemplares similares

Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology
por: Zhang, Xiaobin, et al.
Publicado: (2020)

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020)

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction
por: Tang, Xiaowei, et al.
Publicado: (2019)

Social and Neurocognitive Deficits in Remitted Patients with Schizophrenia, Schizoaffective and Bipolar Disorder
por: Dehelean, Liana, et al.
Publicado: (2021)

Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia
por: Du, Xiangdong, et al.
Publicado: (2020)

Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition
por: Romero-Ferreiro, Verónica, et al.
Publicado: (2022)

Relating self‐disorders to neurocognitive and psychopathological measures in first‐episode schizophrenia
por: Sandsten, Karl Erik, et al.
Publicado: (2022)

Face and object visual working memory deficits in first-episode schizophrenia correlate with multiple neurocognitive performances
por: Liu, Yi, et al.
Publicado: (2021)

Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms
por: Yang, Haidong, et al.
Publicado: (2022)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms
por: Yang, Xu, et al.
Publicado: (2022)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
por: Rodríguez, Natalia, et al.
Publicado: (2022)

“A Cross Sectional Study Of The Neurocognitive Status And Disability Status Between First Episode And Multiple Episode Schizophrenia Patients”
por: Jalak, Prashant, et al.
Publicado: (2022)

Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state
por: Kriesche, Dominik, et al.
Publicado: (2022)

Neurocognitive and clinical correlates of insight in schizophrenia
por: Raveendranathan, Dhanya, et al.
Publicado: (2020)

Social withdrawal and neurocognitive correlates in schizophrenia
por: De Donatis, Domenico, et al.
Publicado: (2022)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Cognitive dysfunction in first-episode schizophrenia and its correlation with negative symptoms and insight
por: Bhat, Pookala Shivaram, et al.
Publicado: (2021)

Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia
por: Huang, Manli, et al.
Publicado: (2016)

Neurocognition and Social Cognition Predicting 1-Year Outcomes in First-Episode Psychosis
por: Lindgren, Maija, et al.
Publicado: (2020)

Neuroimaging and Neurocognitive Correlates of Aggression and Violence in Schizophrenia
por: Weiss, Elisabeth M.
Publicado: (2012)

Distinct Associations of Cognitive Impairments and Reduced Gray Matter Volumes in Remitted Patients with Schizophrenia and Bipolar Disorder
por: Sun, Ting, et al.
Publicado: (2020)

Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia
por: Zhong, Xiao, et al.
Publicado: (2021)

Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
por: Beyazyüz, Murat, et al.
Publicado: (2014)

Linguistic and neurocognitive correlates of probabilistic classification learning in schizophrenia
por: Fernandez, Vindia G., et al.
Publicado: (2021)

Correlation of neurocognitive deficits with positive and negative symptoms in schizophrenia
por: Priyamvada, Richa, et al.
Publicado: (2021)

Violence, neurocognitive function and clinical correlates in patients with schizophrenia
por: Yi, Yun, et al.
Publicado: (2023)

Ten year neurocognitive trajectories in first-episode psychosis
por: Barder, Helene E., et al.
Publicado: (2013)

Estimation of the cool executive function using frontal electroencephalogram signals in first-episode schizophrenia patients
por: Yu, Yi, et al.
Publicado: (2016)

Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia
por: Settem, V. V. Jagadeesh, et al.
Publicado: (2019)

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls
por: Shi, Jing, et al.
Publicado: (2022)

Subjectively-assessed cognitive impairment and neurocognition associations in schizophrenia inpatients
por: Masuzawa, Tatsuhiko, et al.
Publicado: (2021)

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
por: Liu, Yong, et al.
Publicado: (2019)

Corrigendum: “Ten year neurocognitive trajectories in first-episode psychosis”
por: Barder, Helene E., et al.
Publicado: (2014)

Re-visiting the nature and relationships between neurological signs and neurocognitive functions in first-episode schizophrenia: An invariance model across time
por: Chan, Raymond C. K., et al.
Publicado: (2015)

T62. COMPARISON OF NEUROCOGNITIVE FUNCTIONS IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS, NON-PSYCHOTIC SIBLINGS, AND INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chu, On Ki, et al.
Publicado: (2018)

Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis
por: Chang, Miao, et al.
Publicado: (2016)

Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment
por: Xiao, Libin, et al.
Publicado: (2022)

Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables
por: Yu, Miao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hrejc26a8dp9drjb603kdnapn7